| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,831,761 | 5,782,679 | 5,582,524 | 8,153,289 | | Cost of Revenue | 5,532,181 | 5,558,684 | 5,473,661 | 7,855,950 | | | Gross Profit | 299,580 | 223,995 | 108,863 | 297,339 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 68,847 | 309,091 | 195,825 | 275,922 | | Non Recurring | 187 | 12,730 | 105,192 | 5,949,977 | | Others | 22,710 | 23,334 | 27,696 | 32,613 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 207,836 | (121,160) | (219,850) | (5,961,173) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (199,398) |
-
| 9,310 | (9,310) | | Earnings Before Interest And Taxes | 8,438 | (121,160) | (210,540) | (5,970,483) | | Interest Expense | 38,091 | 36,886 | 47,115 | 41,704 | | Income Before Tax | (29,653) | (158,046) | (257,655) | (6,012,187) | | Income Tax Expense | (49,312) | (4,003) | (17,858) | 2,947 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 19,659 | (154,043) | (239,797) | (6,015,134) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 19,659 | (154,043) | (239,797) | (6,015,134) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $19,659 | ($154,043) | ($239,797) | ($6,015,134) |
|
0.11% Nasdaq 
0.01%
Income Statement
